Table 1.

Comparison of the two groups of patients (empirical and targeted antibiotic groups)

Variable	Targeted (n=50)	Empirical (n=50)	Total (n=100)	P
Age
40-49	4	1	4	0557
50-59	15	34	65
60-69	50	15	31
70-79	24
80-89	7
PSA
<4.0	1	0	1	0.662
4.0-10	19	18	37
10-20	21	23	44
20-100	1	3	4
>100	8	6	14
Prostate size				0.201
<40	4	1	5
40-100	19	26	45
>100	27	23	50
Histology
BPH	35	36	71	0.662
Adenocarcinoma	15	14	29
LUTS
Yes	41	50	91	0.002
No	9	0	9
Comorbidity (diabetes)
Yes	10	12	22	0.629
No	40	38	78
Metastasis
Yes	4	3	7	0.695
No	46	47	93
Postbiopsy infection
Yes	1	5	6	0.042
No	49	45	94

PSA=Prostate-specific antigen, LUTS=Lower urinary tract symptoms, BPH=Benign prostatic hyperplasia